diabetes motality clinical trial

A randomized clinical trial followed men for 3.8 years to see if testosterone replacement therapy (TRT) reduced mortality in men with type 2 diabetes mellitus (T2DM). It did, even though it had no effect on cardiovascular disease (CVD). rates. The abstract says: "We studied 857 men with T2DM...